EpiPen's price has ballooned about 400% since 2008, rising from about a $100 list price to $500 today. The EpiPen is one of the most important life-saving medical innovations for people with severe food allergies—which affect as many as 15 million Americans and 1 in 13 children in the United States. But its price has exploded over the last decade despite few upgrades to the product itself. The product's lack of competitors is likely a significant driver of the costs. [...] [The] EpiPen enjoys a near-monopoly on the market with annual sales of more than $1.3 billion and nearly 90% U.S. market share.
(Score: 1, Informative) by Anonymous Coward on Wednesday August 24 2016, @02:00AM
The largest cost for a new drug is marketing, none of that boring research stuff.
Also if you don't pay to send doctors on junkets, who is going to trick all your customers into buying your 'medicine'?